Learn when to report suspected drug diversion to the FDA's Office of Criminal Investigations with insights from Terri Vidals and FDA Special Agent Ronne Malham.
Reporting Drug Diversion: A Chat with FDA Special Agent Ronne Malham
We can definitely bring experience into the situation. We can look at what has been done in that particular instance. You're a better interviewer than most of us have in our facility. We're going to work with our partners to investigate that issue.
Ever wondered about the right time to report suspected drug diversion? In this episode of 'Drug Diversion Insights', host Terri Vidals sits down with Ronne Malham, FDA Special Agent in Charge, to discuss the critical role of the FDA's Office of Criminal Investigations (OCI). They dive into the nitty-gritty of when and why you should report cases of diversion or tampering to the OCI.
Ronne shares valuable insights on how the OCI collaborates with state and local partners to protect public health and safety. You'll also learn about the educational efforts and outreach programs that the OCI offers to help detect and prevent drug diversion. This episode is a must-listen for anyone in the healthcare field looking to understand the importance of timely reporting and collaboration with federal agencies.